Innate Immune B Cell Activation by Leishmania donovani Exacerbates Disease and Mediates Hypergammaglobulinemia. by Silva-Barrios, Sasha et al.
HAL Id: pasteur-01351549
https://hal-riip.archives-ouvertes.fr/pasteur-01351549
Submitted on 3 Aug 2016
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives| 4.0
International License
Innate Immune B Cell Activation by Leishmania
donovani Exacerbates Disease and Mediates
Hypergammaglobulinemia.
Sasha Silva-Barrios, Mélina Smans, Claudia U Duerr, Salman T Qureshi, Jörg
H Fritz, Albert Descoteaux, Simona Stäger
To cite this version:
Sasha Silva-Barrios, Mélina Smans, Claudia U Duerr, Salman T Qureshi, Jörg H Fritz, et al.. Innate
Immune B Cell Activation by Leishmania donovani Exacerbates Disease and Mediates Hypergamma-
globulinemia.. Cell Reports, Elsevier Inc, 2016, 15 (11), pp.2427-37. ￿10.1016/j.celrep.2016.05.028￿.
￿pasteur-01351549￿
ArticleInnate Immune B Cell Activation by Leishmania
donovani Exacerbates Disease and Mediates
HypergammaglobulinemiaGraphical AbstractHighlightsd Leishmania donovani triggers endosomal TLRs in B cells
d Innate B cell activation results in IL-10 and type I IFN
induction
d IFN-I is involved in a positive regulatory loop enhancing
cytokine and TLR expression
d Innate B cell activation and IFN-I govern antibody production
during diseaseSilva-Barrios et al., 2016, Cell Reports 15, 2427–2437
June 14, 2016 ª 2016 The Author(s).
http://dx.doi.org/10.1016/j.celrep.2016.05.028Authors
Sasha Silva-Barrios, Me´lina Smans,
Claudia U. Duerr, Salman T. Qureshi,
Jo¨rg H. Fritz, Albert Descoteaux,
Simona Sta¨ger
Correspondence
simona.stager@iaf.inrs.ca
In Brief
Silva-Barrios et al. report that the parasite
Leishmania donovani triggers endosomal
TLRs in B cells. This activation induces
cytokine and endosomal TLR expression,
which are further enhanced by signaling
through the type I IFN receptor. Innate
B cell activation through endosomal TLRs
and IFN-I promotes disease exacerbation
and hypergammaglobulinemia.
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Participation of B cells in the immune response
by various antibody-independent mechanisms has
recently been uncovered. B cells producing cyto-
kines have been described for several infections
and appear to regulate the adaptive immune
response. B cell activation by Leishmania donovani
results in disease exacerbation. How Leishmania
activates B cells is still unknown. We show that
L. donovani amastigotes activate B cells by trig-
gering endosomal TLRs; this activation leads to the
induction of various cytokines. Cytokine expression
is completely abrogated in B cells from Ifnar/
mice upon exposure to L. donovani, suggesting an
involvement of IFN-I in a positive feedback loop.
IFN-I also appears to enhance the expression of en-
dosomal TLRs following exposure to L. donovani.
Cell-specific ablation of endosomal TLR signaling in
B cells revealed that innate B cell activation by
L. donovani is responsible for disease exacerbation
through IL-10 and IFN-I production and for the pro-
motion of hypergammaglobulinemia.INTRODUCTION
The main mechanisms leading to antibody production by B cells
are largely known. Follicular helper CD4+ T cells (TFhs) are
thought to play a crucial role in germinal center formation and
B cell differentiation into antibody-producing plasma cells
(Crotty, 2011); antigen-specific B cell receptor (BCR) recognition
is required for this process. Nevertheless, other pathways have
been reported to be involved in enhancing antibody production.
For instance, Toll-like receptor (TLR) stimulation in B cells can
regulate themagnitude of the antibody response and the amount
of antigen required for initiating BCR signaling (DeFranco et al.,
2012; Freeman et al., 2015). Moreover, Myd88/ B cells wereCell
This is an open access article under the CC BY-Nreported to generate decreased antibody responses (Pasare
and Medzhitov, 2005; Kasturi et al., 2011).
The role of B cell TLR signaling in antibody production has
mainly been studied in models of autoimmune diseases. TLR7
and 9 were shown to contribute importantly to the production
of anti-nuclear antibodies in variousmodels of lupus-like disease
(Christensen et al., 2006; Han et al., 2015). In contrast, little is
known about the role of B cell TLR signaling in infectious dis-
eases. MyD88 appears to be required for preventing lethal
dissemination of commensal bacteria during colonic damage
caused by dextran sulfate sodium (Kirkland et al., 2012). In this
model, MyD88 was essential for the production of immunoglob-
ulinM (IgM) and complement by B cells. TLR9, TLR7, andMyD88
expression in B cells was also shown to be involved in substan-
tially enhancing T cell-dependent germinal center immunoglob-
ulin G (IgG) responses following inoculation with virus-like
particles (Hou et al., 2011). DuringSalmonella typhimurium infec-
tion, however, MyD88 in B cells was mainly associated with
cytokine production and led to disease susceptibility via inter-
leukin-10 (IL-10) induction (Neves et al., 2010).We have also pre-
viously reported that B cell-derived IL-10 production following
Leishmania donovani infection was dependent on MyD88
expression in B cells (Bankoti et al., 2012).
The protozoan parasite L. donovani is a causative agent of
visceral leishmaniasis (VL), a chronic disease that is character-
ized, among others, by polyclonal B cell activation and hyper-
gammaglobulinemia. Leishmania is an intracellular parasite that
preferentially infectsmacrophages; however, it can alsobe found
in dendritic cells, neutrophils, and fibroblasts (Kaye and Scott,
2011). In a previous study, we have shown that L. donovani can
also be detected on marginal zone B cells (Bankoti et al., 2012).
In the murine model of VL, B cells play a detrimental role (Smelt
et al., 2000). IgM, complement, and B cell-derived IL-10 largely
contribute to disease susceptibility (Deak et al., 2010; Bankoti
et al., 2012). Additionally, IgG immune complexes were shown
to exacerbate infection by inducing IL-10 production in macro-
phages (Miles et al., 2005). IgG is also linked to chronic infection
in human VL patients, where high IgG levels are predictive of dis-
ease. However, the pathways leading to polyclonal B cell activa-
tion and hypergammaglobulinemia in VL are still unknown.Reports 15, 2427–2437, June 14, 2016 ª 2016 The Author(s). 2427
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. L. donovani Promotes Cytokine
mRNA Expression in B Cells
(A) Naive splenic B cells were exposed to PKH67-
labeled L. donovani amastigotes (green) at an MOI
of 1:5 for 5 hr. Cells were stained with anti-IgM-
AF568 (red) and Hoechst (blue) and visualized by
confocal microscopy.
(B and C) Expression analysis by qPCR of cytokine
mRNA in naive splenic B cells exposed to
L. donovani for 8 hr (B) and in splenic B cells pu-
rified from infected mice (C). Data represent
mean ± SEM from three independent experiments.In this study, we investigate the mechanisms of B cell activa-
tion by L. donovani. We show that L. donovani amastigotes acti-
vate B cells by triggering endosomal TLRs. This activation
resulted in the induction of proinflammatory cytokines, IL-10,
and type I interferon (IFN) and in the upregulation of endosomal
TLR expression. Upregulation of cytokine and endosomal TLR
mRNA expression was dependent on the presence of type I
IFN receptor (IFNaR) in B cells, suggesting an involvement of
type I IFNs in a positive regulatory loop. A functional endosomal
TLR pathway was also required to generate non-specific and
Leishmania-specific antibodies. These results demonstrate that
B cell activation by L. donovani through endosomal TLRs leads
to disease exacerbation through type I IFN production and the
promotion of hypergammaglobulinemia.
RESULTS
L. donovani Triggers IL-10 and Type I IFN Expression in
Splenic B Cells
Wehave previously reported that B cells can capture L. donovani
amastigotes in vivo and in vitro (Bankoti et al., 2012). Upon2428 Cell Reports 15, 2427–2437, June 14, 2016in vitro exposure to the parasite, B cells
form clusters, upregulate the costimula-
tory molecule CD86 and surface IgM,
and eventually die after 48 hr (Bankoti
et al., 2012). Confocal microscopy anal-
ysis revealed that this interaction does
not result in parasite internalization but
that L. donovani is retained on the surface
in IgM-rich pockets (Figure 1A; Movies S1
and S2). B cell activation also resulted in
the expression of several cytokines (Fig-
ure 1B), with IL-10 and IFN-b being the
most highly expressed. Maximal cytokine
expression was reached after 8 hr of co-
incubation with the parasite (Figure S1).
A similar pattern of cytokine expression
was also observed in B cells purified
from L. donovani-infected mice (Fig-
ure 1C). Interestingly, IL-10 and IL-1a
mRNAs were mainly upregulated during
the early stages of infection (days 7–14),
whereas type I IFN and IL-6 were promi-
nently expressed during the chronicphase of the disease (days 21–28). We have previously reported
that IL-10 secretion is MyD88-dependent (Bankoti et al., 2012).
The pathways upstream of MyD88 and of IFN-I induction in
B cells following exposure to L. donovani are as yet unknown.
L. donovani Activates Endosomal TLRs in B Cells
Because MyD88 is necessary for IL-10 production in B cells
(Bankoti et al., 2012), and L. donovani is recognized by a number
of TLRs (Paun et al., 2011; Flandin et al., 2006; Kropf et al., 2004;
Schleicher et al., 2007), we next investigated the role of TLRs in
cytokine induction by the parasite. First, we assessed whether
TLR agonists could induce a pattern of cytokines in B cells
similar to that observed after exposure to L. donovani. Interest-
ingly, agonists to TLR3, 7, and 9 triggered the strongest upregu-
lation of mRNA for IL-1a, IL-1b, IL-6, IL-10, and IFN-a/b
(Figure 2A) after 8 hr of exposure, suggesting that, although
the parasite resides on the cell surface, endosomal TLRs may
be triggered by L. donovani in B cells. We next examined, by
confocal microscopy, the expression of TLR3 (Figure 2B, top)
and TLR9 (Figure 2B, bottom) on splenic murine B cells exposed
to the parasite. TLR3 and 9 were more intensely present at the
Figure 2. B Cells Express Endosomal TLRs and Respond to TLR Agonist Stimulation
(A) Cytokine mRNA expression by qPCR in splenic B cells activated with TLR agonists for 8 hr.
(B) TLR3 and TLR9 localization by confocal microscopy in B cells exposed or not exposed to L. donovani (green) and stained with anti-IgM-AF568 (red), anti-
TLR3-Dylight 650 (white), or anti-TLR9-ZenonAF647 (white) and Hoechst (blue).
(C) Immunoblot analysis for TLR7 in B cells exposed to different ratios of parasites or R837-activated and parasites alone (LV9).
Data represent mean ± SEM from three independent experiments.site of contact with the parasite (Figure 2B), suggesting that en-
dosomal TLRs might be activated by Leishmania amastigotes.
The presence of TLR7 in murine B cells was determined by west-
ern blot (Figure 2C).
B Cell Cytokine Expression following In Vitro Exposure
to L. donovani Is Dependent on Endosomal TLRs and the
IFNAR
To confirm our hypothesis that endosomal TLRs are required for
cytokine induction, we exposed splenic B cells purified from
Unc931bLetr/Letr mice (Lafferty et al., 2014) to the parasite
in vitro and assessed cytokine expression. Unc931bLetr/Letr
mice (Lafferty et al., 2014) have a loss-of-function mutation,
known as Letr for ‘‘loss of endosomal TLR response,’’ in
Unc93b1, which is a chaperone protein for TLR3, TLR7, and
TLR9. All cytokine mRNA levels measured failed to be upre-
gulated in Unc93b1Letr/Letr B cells exposed to L. donovanicompared with wild-type (WT) B cells (Figure 3A), suggesting
that activation of endosomal TLR pathways was indeed respon-
sible for cytokine expression in B cells. Our results were
confirmed using TLR7 and 9 inhibitors (Figure S2). Strikingly,
cytokine expression was also abrogated in B cells lacking the
IFN-I receptor (IFNAR) (Figure 3A), implying that IFN-a/b may
be involved in a positive feedback-regulatory loop. IFN-I
signaling was shown to directly regulate TLR7 expression and
TLR7 responsiveness by B cells (Doucett et al., 2005; Green
et al., 2009; Thibault et al., 2009). Thus, we examined endosomal
TLR mRNA expression in B cells purified from C57BL/6 and
Unc931bLetr/Letr mice following in vitro exposure to L. donovani.
Activation by the parasites led to the upregulation of endosomal
TLR expression in wild-type B cells (Figure 3B). In contrast, en-
dosomal TLR mRNAs failed to be upregulated in the absence
of the IFNAR or in Unc931bLetr/Letr B cells (Figure 3B). To deter-
mine whether endosomal TLR expression was also dependentCell Reports 15, 2427–2437, June 14, 2016 2429
Figure 3. Functional Endosomal TLRs and
IFNARs Are Involved in Cytokine and TLR
mRNA Expression in B Cells
(A and B) Expression analysis by qPCR of cytokine
(A) and endosomal (B) TLR mRNA in B cells from
C57BL/6, Unc93b1Letr/Letr, and Ifnar/ mice
exposed to L. donovani. Data represent mean ±
SEM from two independent experiments (n = 6–8).
(C) TLR mRNA expression in B cells from infected
chimeric mice assessed by qPCR. Data are ex-
pressed as fold increase to naive chimeric mice.
mMT-C57BL/6 mice were used as comparison
group for statistical significance. Data represent
mean ± SEM of one of two independent experi-
ments (n = 4–5). *p < 0.05, **p < 0.01, ***p < 0.001.on IFN-I signaling in vivo, we generated a mixed bone marrow
chimera with a targeted ablation of IFNAR in B cells. Chimeric
mice were then infected with L. donovani, and B cells were puri-
fied at various time points after infection. Our in vitro results were
confirmed in vivo. IFN-I signaling not only regulated TLR7
expression but was also involved in the upregulation of TLR3
and 9 (Figure 3C).
UNC93b1 Deficiency Abrogates IFN-I and IL-10 mRNA
Upregulation in B Cells during L. donovani Infection
To determine whether cytokine expression was also lost in vivo
in the absence of functional endosomal TLR pathways or the
IFNAR, we generated mixed bone marrow chimeras with a spe-
cific ablation of UNC93b1 or the IFNAR in B cells. B cell reconsti-
tution levels were evaluated 6 weeks after bone marrow transfer;
no significant differences were observed among the three
groups (Figure S3).We then purified B cells at various time points
after infection from L. donovani-infected chimeric mice. With
exception of IL-1b and IL-6, most of the cytokine expression
was lost in B cells from infected mMT-Unc93b1Letr/Letr chimeric
mice (Figure 4), indicating that endosomal TLR activation was
the main pathway leading to cytokine induction in vivo as well.
Similar results were obtained in mMT-Ifnar/mice, underscoring
the important role played by the IFNAR in vivo in enhancing B cell2430 Cell Reports 15, 2427–2437, June 14, 2016activation by L. donovani. Interestingly, B
cells from infected mMT-Unc93b1Letr/Letr
chimeric mice had a similar surface mod-
ulation of the costimulatory molecules
CD80, CD86, and CD40 (Figure S4) as
mMT- C57BL/6 and mMT-Ifnar/ mice,
suggesting that endosomal TLR path-
ways were not the only pathways trig-
gered by L. donovani to activate B cells
and that induction of cytokine expression
was solely dependent on functional endo-
somal TLR signaling.
Lack of Functional Endosomal TLR
Signaling in B Cells Results in
Enhanced Th1 Responses
We next sought to determine the bio-
logical relevance of endosomal TLRsignaling in B cells during L. donovani infection. To this end,
we infected mMT-Unc93b1Letr/Letr and mMT-Ifnar/ chimeric
mice and their wild-type controls (mMT-C57BL/6) with
L. donovani amastigotes and monitored the cellular and hu-
moral immune responses to the parasite. We first moni-
tored the development of protective IFN-g-producing CD4
T cells in the three groups of mice. mMT-Unc93b1Letr/Letr mice
displayed a trend toward increased frequencies of IFN-g+
CD4+ T cells on days 14 and 21 post infection (p.i.) compared
with the control group (Figures 5A and 5B). In addition, the
mean fluorescence intensity for IFN-g in the same group of
animals was significantly higher on day 21 p.i. (Figure 5C).
A characteristic of chronic L. donovani infection is the
appearance of CD4 T cells co-producing IFN-g and IL-10.
These cells are thought to have immune-suppressive func-
tions and are typically associated with disease progression in
humans and mice (Nyle´n et al., 2007; Sta¨ger et al., 2006).
Interestingly, the frequency of IFN-g+ IL-10+ CD4+ T cells
was significantly lower on day 28 p.i. in mMT-Unc93b1Letr/Letr
mice compared with the control group (Figures 5D and 5E).
Although infected mMT-Ifnar/ mice showed stronger Th1 re-
sponses and slightly lower frequencies of IFN-g+IL-10+ CD4+
T cells, the differences were not significant at any time point
analyzed.
Figure 4. Cytokine mRNA Expression in B Cells during VL Requires
Functional Endosomal TLRs and IFNARs
Cytokine mRNA expression in B cells from infected chimeric mice was as-
sessed by qPCR. Data represent mean ± SEM of one of two independent
experiments (n = 4–5). *p < 0.05, **p < 0.01, ***p < 0.001.B Cell Endosomal TLR and IFN-I Are Involved in
Hypergammaglobulinemia Induction during L. donovani
Infection
TLR signaling in B cells is known to potentiate antibody produc-
tion in autoimmune diseases (Han et al., 2015). Because
L. donovani induces a very strong antibody response that is
detrimental to infection (Deak et al., 2010; Miles et al., 2005),
we assessed whether ablation of TLR signaling in B cells would
affect the humoral response to the parasite. First, we measured
total IgG levels in the sera of infected mice over the course ofinfection, and we noticed an extreme reduction in serum IgG in
mMT-Unc93b1Letr/Letr and mMT-Ifnar/ mice compared with
the control group (Figure 6A). Serum IgM levels were also signif-
icantly reduced, especially on day 14 p.i. Interestingly, both
chimeric mouse groups failed to generate an IgM response
following infection (Figure 6B). We also found a significant
reduction in Leishmania-specific IgG antibody levels in mMT-
Unc93b1Letr/Letr and mMT-Ifnar/ mice compared with the con-
trol group (Figure 6C). Collectively, our results indicate that
endosomal TLR signaling in B cells strongly enhances antibody
production during L. donovani infection and may thus contribute
to hypergammaglobulinemia. The mechanism of induction
partially requires signaling through the IFNAR because mMT-
Ifnar/ mice showed an intermediate phenotype with respect
to the humoral response (Figures 6A–6C).
To exclude a possible intrinsic B cell defect in our knockout
mice, we next immunized Unc93b1Letr/Letr, Ifnar/, and WT
control mice with ovalbumin using saponin as an adjuvant.
Immunized Unc93b1Letr/Letr produced a lower amount of oval-
bumin-specific IgG after the first immunization compared with
WT mice. However, when mice were boosted, no significant dif-
ferences were observed between Unc93b1Letr/Letr and WT mice
(Figure 6D). Ifnar/ showed a similar response to immunization
as WT mice (Figure 6E). This suggests that UNC93b1- and
IFNAR- deficient B cells are capable of producing antigen-spe-
cific antibodies following an immunization that does not require
TLR activation.
B Cell Endosomal TLR Activation by L. donovani
Exacerbates Infection
Finally, we examined the contribution of B cell endosomal TLR
signaling on the parasite burden. L. donovani typically estab-
lishes chronic infection in the spleen, whereas the parasite is
eliminated in the liver. As expected, no major differences in he-
patic parasite burden were observed between the three groups
of chimeric mice (Figure 7A), suggesting that endosomal
TLR signaling in B cells does not substantially contribute to dis-
ease resolution or exacerbation in the liver. In contrast, mMT-
Unc93b1Letr/Letr mice were remarkably resistant to L. donovani
infection in the spleen, where we observed an 84% reduction
in the splenic parasite burden (Figure 7B). These results demon-
strate the detrimental role of innate immune B cell activation dur-
ing visceral leishmaniasis.
DISCUSSION
This study identifies endosomal TLRs as a major pathway of
B cell activation by L. donovani. Endosomal TLR activation in
B cells induced cytokine expression, promoted antibody pro-
duction, and led to disease exacerbation. The IFNAR was
required to enhance this effect.
With exception of IL-10 (Bankoti et al., 2012; Deak et al., 2010;
Ronet et al., 2010), the role of B cell-derived cytokines in leish-
maniasis has not yet been investigated. We have previously re-
ported that B cell-derived IL10 is MyD88-dependent (Bankoti
et al., 2012). In this study, we extend our observation to demon-
strate that not only IL-10 but also IL-1, IL-6, and IFN-I are down-
stream of endosomal TLR signaling following exposure toCell Reports 15, 2427–2437, June 14, 2016 2431
Figure 5. Enhanced Th1 Responses and Lower Frequencies of IFN-g+ IL-10+ CD4+ T cells in mMT-Unc93b1Letr/Letr chimeric mice
Splenocytes from infected mMT-C57BL/6, mMT-Unc93b1Letr/Letr, and mMT-Ifnar/ mice were stained for CD3, CD4, IFN-g, and IL-10 after restimulation.
(A) Representative fluorescence-activated cell sorting (FACS) plots for IFN-g+ CD4+T cells.
(B and C) Percentage of IFN-g+ (B) and mean fluorescence intensity (C) of IFN-g in CD4+T cells. Splenocytes were restimulated with PMA/ionomycin for 4 hr and
stained for CD3, CD4, IFN-g, and IL-10.
(D) Representative FACS plots for IFN-g+ IL-10+ CD4+T cells.
(E) Percentage of IFN-g+ IL-10+ CD4+ T cells. Data represent mean ± SEM of one of two independent experiments (n = 5). *p < 0.05, **p < 0.01, ***p < 0.001.L. donovani amastigotes. B cell activation through endosomal
TLRs was reported so far only for autoimmune diseases (Avalos
et al., 2014; Han et al., 2015) or in a context of vaccination (Hou
et al., 2011). Lipopolysaccharides (LPS) and CpG DNA also
appear to enhance signaling through the BCR in vitro (Freeman
et al., 2015). In contrast, MyD88 expression on B cells was
shown to suppress protective immunity against Salmonella
(Neves et al., 2010) through IL-10 production. In this model,
the pathways upstream of MyD88 were not investigated. Never-
theless, the requirement for MyD88may suggests a role for TLRs
in B cell activation and IL-10 induction. TLR signals are also
required for the development of regulatory B10 cells (Yanaba
et al., 2009).
A large body of literature has nowdemonstrated that cytokines
produced by B cells contribute to the regulation of the adaptive
immune response and can inhibit dendritic cells (DC) andmacro-
phage functions. In our infection model, B cell-derived cytokines
probably do not play a major role in regulating T cell responses.2432 Cell Reports 15, 2427–2437, June 14, 2016Indeed, we only observed mild differences in T cell responses
between mMT-C57BL/6, mMT-Unc93b1Letr/Letr, and mMT-
Ifnar/, suggesting that B cell-derived cytokines are mainly
involved in regulating innate myeloid cell functions. An inter-
esting observation, however, was the induction of IFN-I expres-
sion by L. donovani. Our results indicate that IFN-a/b may act
through autocrine signaling to enhance B cell activation. Indeed,
in the absence of a functional IFNAR, cytokine expression was
abrogated in B cells exposed in vitro to L. donovani or purified
from infected mice. IFN-Is are known to exert pleiotropic effects
on B cells (Ivashkiv and Donlin, 2014), including enhanced IL-10
production through TLR7/8 in B cells (Liu et al., 2014), induction
of marginal zone B cells (MZB) follicular shuttling (Li et al., 2015),
stimulation of B cell-activating factor (BAFF) production inmono-
cytes (Gomez et al., 2015), and enhancement of antibody re-
sponses by promotion of isotype switching (Le Bon et al., 2001).
In VL, we demonstrate that IFN-I signaling is also involved in
the upregulation of TLR3, 7, and 9 in B cells. A positive feedback
Figure 6. Endosomal TLRs and IFNARs in B Cells Promote Hypergammaglobulinemia
(A–C) Total levels of IgG (A), IgM (B), and Leishmania-specific IgG (C) in the sera of infected mMT-C57BL/6, mMT-Unc93b1Letr/Letr, and mMT-Ifnar/mice over the
course of infection. Data represent mean ± SEM of one of two independent experiments (n = 4–5). O.D., optical density.
(D and E) C57BL/6, Ifnar/, andUnc93b1Letr/Letr micewere immunized with ovalbumin and saponin. The graphs show the level of ovalbumin-specific IgG in the sera
of immunized mice at various time points after immunization. Data represent mean ± SEM of one of two experiments (n = 5–6). *p < 0.05, **p < 0.01, ***p < 0.001.loop involving IFN-b and TLR7 has also been proposed by Green
et al. (2009). In our model, the interplay between IFN-I and
endosomal TLRs has been extended to the regulation of the
humoral response. The fact that treatment with IFN-I can lead
to lupus-like symptoms (Gota and Calabrese, 2003) suggests
that this positive loop may apply to other diseases. A possible
role for IFN-I in enhancing antibody production has already
been ascribed to various models of viral infections (Lund
et al., 2004, Heer et al., 2007) and seem to be mainly dependent
on IFNAR expression in B cells (Marzo et al., 2005). However,
a direct role for B cell TLRs in regulating the humoral
response was only demonstrated in autoimmune diseases. For
instance, TLR7 and 9 in B cells have been shown to be
involved in enhancing autoantibody production in systemic
Lupus Erythematosus (SLE) (Christensen et al., 2006, Han
et al., 2015). Moreover, in patients suffering fromWiskott-Aldrich
syndrome, increased TLR signaling in B cells promotes the
enrichment of self-reactive transitional B cells (Kolhatkar et al.,
2015). Our study demonstrates that a parasite can directly
activate endosomal TLRs in B cells and that this activation re-
sults in enhanced non-specific and Leishmania-specific anti-
body production.
Hypergammaglobulinemia, which commonly leads to anti-
body-mediated immunopathology, is a hallmark of VL. The
mechanisms leading to hypergammaglobulinemia in VL are
poorly understood. A recent study conducted in human VL pa-
tients revealed that serum levels of the B cell-activating factor
BAFF were elevated during active disease (Goto et al., 2014).However, a clear positive correlation between BAFF and IgG
levels in VL patients was not found. Hence, the authors sug-
gested that other factors may act synergistically with BAFF to
promote hypergammaglobulinemia. During chronic lymphocytic
choriomeningitis virus (LCMV), hypergammaglobulinemia and
autoantibody production arise when B cells process viral antigen
and present it to TFhs (Hunziker et al., 2003). Interestingly, viral
antigen processing did not require BCR, complement receptors,
or Fc receptors. We also observed with Leishmania that induc-
tion of cytokine expression was not dependent on a specific
BCR (data not shown), suggesting that perhaps Leishmania
antigens are also internalized by a non-specific pinocytosis of
either parasite exosomes or surface molecules cleaved by
B cell proteases. The role of TFhs in VL has recently been clari-
fied in a study in macaques (Rodrigues et al., 2014). TFhs appear
to expand during acute infection, paralleling the differentiation of
activatedmemory B cells and the production of parasite-specific
IgG. In contrast, the authors observed a contraction of germinal
centers during chronic infection, confirming results reported pre-
viously in experimental VL (Smelt et al., 1997). This contraction
affected the production of parasite-specific IgG, whereas hyper-
gammaglobulinemia persisted. Hence, it appears that TFhs may
play a limited role in the maintenance of hypergammaglobuline-
mia during VL. Nevertheless, it is possible that TLR-activated
B cells may induce abortive TFh responses while enhancing
the production of non-specific antibodies. Further investigations
are warranted to understand the interaction between these two
cell populations.Cell Reports 15, 2427–2437, June 14, 2016 2433
Figure 7. Endosomal TLRs in BCells Contributes to VL Exacerbation
(A and B) Liver (A) and splenic (B) parasite burden in chimeric mice over the
course of infection, represented as LDUs. Data represent mean ± SEM of one
of two independent experiments (n = 4–5). *p < 0.05,**p < 0.01.In conclusion, we discovered that a parasite can directly acti-
vate endosomal TLRs in B cells. We propose that this activation
is largely responsible for promoting hypergammaglobulinemia in
an IFNAR-dependent manner. Hypergammaglobulinemia and
elevated levels of IFN-I are characteristics of several chronic in-
fections and autoimmune diseases and are often associated
with immunosuppression and/or increased pathology. Thus,
innate activation of B cells may be an unappreciated mechanism
that underlies the development of hypergammaglobulinemia and
may therefore contribute to immunopathology in other chronic
infections.
EXPERIMENTAL PROCEDURES
Mice and Parasites
C57BL/6 and mMT mice were purchased from The Jackson Laboratory.
Unc93b1Letr/Letr (Lafferty et al., 2014) and Ifnar/ (M€uller et al., 1994) mice
were bred at the animal facility of McGill University. All mice were housed at2434 Cell Reports 15, 2427–2437, June 14, 2016the Institut National de la Recherche Scientifique (INRS) animal facility under
specific pathogen-free conditions and used at 6–12 weeks of age. Experi-
ments involvingmice were carried out under protocols approved by the Animal
Care and Use Committee of the INRS, Institut Armand-Frappier. These proto-
cols respect procedures on good animal practice provided by the Canadian
Council on Animal Care.
L. donovani (strain LV9) was maintained by serial passage in B6.129S7-
Rag1tm1Mom mice, and amastigotes were isolated from the spleens of infected
animals. Mice were infected by injecting 23 107 amastigotes intravenously via
the lateral tail vein (Sta¨ger et al., 2003). Splenic parasite burdens were deter-
mined by examining methanol-fixed, Giemsa-stained tissue impression
smears. Data are presented as number of parasites per spleen or as Leishman
Donovan Units (LDUs) (Bankoti et al., 2012).
B Cell In Vitro Studies
Naive splenic B cells were purified using the B cell isolation kit (Miltenyi
Biotech) according to the manufacturer’s protocol. Purified B cells (purity
90%–92%) were then incubated either alone, with different ratios of parasites,
or with TLR agonists: 3 mg/ml CpG (InvivoGen), 5 mg/ml R837 (InvivoGen),
3 mg/ml poly (I:C) (Amersham), and 10 mg/ml LPS (Sigma). B cells were also
incubated with 1 mg/ml ODN2088 (Miltenyi) and a TLR7 and 9 inhibitor (Stunz
et al., 2002). Cells were cultured in supplemented DMEM (Gibco, Invitrogen).
For cytokine mRNA expression analysis, confocal microscopy, and immuno-
blots, cells were incubated for 8 or 24 hr at 37C.
Quantitative Real-Time PCR
RNA from isolated B cells from in vitro or in vivo experiments was extracted us-
ing the RNeasy mini kit (QIAGEN) as described by the manufacturer. Reverse
transcription was carried out using the iScript cDNA synthesis kit (Bio-Rad)
following the manufacturer’s protocol. Real-time PCR analysis was performed
using iTaq Universal SYBR Green Supermix (Bio-Rad). The IL-1a, IL-1b, IL-6,
IL-10, IFN-a, IFN-b, and HPRT genes were amplified using primers whose se-
quences are described below. All PCRs were carried out with the Stratagene
mx3005p real-time PCR system. Data were normalized to HPRT and ex-
pressed as fold increase to naive controls.
Primers
The following primers were used to determine the relative gene expression us-
ing qPCR: Hprt, 50-GTT GGA TAC AGG CCA GAC TTT GTT G-30 and 50-GAT
TCA ACC TTG CGC TCA TCT TAG GC-30; Il1a, 50-CAA ACT GAT GAA GCT
CGT CA-30 and 50-TCT CCT TGA GCG CTC ACG AA-30; Il1b, 50-AAC CTG
CTG GTG TGT GAC GTT C-30 and 50-CAG CAC GAG GCT TTT TTG TTG
T-30; Il6, 50-ACA ACC ACG GCC TTC CCT ACT T-30 and 50-CAC GAT TTC
CCA GAG AAC ATG TG-30; Il10, 50-AGG GTT ACT TGG GTT GCC AA-30 and
50-CAC AGG GGA GAA ATC GAT GA-30; Ifna, 50-CAT CTG CTG CTT GGG
ATG GAT-30 and 50-TTC CTG GGT CAG AGG AGG TTC-30; Ifnb, 50-TCA
GAA TGA GTG GTG GTT GC-30 and 50-GCA CTT TCA AAT GCA GTA GAT
TCA-30; Tlr3, 50-AAG ACA GAG ACT GGG TCT GGG-30 and 50-TGA AAC
TTC GTC CGC AGG AA-30; Tlr7, 50-GGC ATT CCC ACT AAC ACC AC-30
and 50-TTG GAC CCC AGT AGA ACA GG-30; and Tlr9, 50-CTA GAT GCT
AAC AGC CTC GCC-30 and 50-GTC CTC GCC ACT TCC ACT G-30.
Confocal Microscopy
L. donovani parasiteswere stainedwith PKH67 (Sigma) following themanufac-
turer’s instructions and incubated with purified naive splenic B cells (B cell
isolation kit, Miltenyi). 2 3 106 B cells were incubated either alone or with
PKH67-L. donovani amastigotes (at a multiplicity of infection [MOI] of 5:1 or
10:1). 8 or 24 hr post-incubation, cells were fixed with 2% paraformaldehyde
for 15min at 4C. Permeabilization and unspecific staining were blocked using
0.1% Triton X-100, 1% bovine serum albumin, 5% goat serum, and 5% horse
serum in PBS for 30 min at 4C. For immunostaining, cells were labeled with
coupled antibodies against BCR (goat anti-mouse IgM-AF568, Life Technolo-
gies), TLR3 (anti-TLR3 antibody (40C1285.6)-DyLight 650, Novus), and TLR9
(anti-TLR9 monoclonal antibody, Abcam) coupled to IgG1 Zenon-Alexa
Fluor-647, Life Technologies). NucBlue (Life Technologies) was used to visu-
alize cell nuclei, following the manufacturer’s instructions. Labeled cells
were washed in PBS and resuspended in 100 ml of PBS and then transferred
onto a polylysine-coated coverslip. Coverslips were subsequently mounted
with mounting medium (Fluoromount G, Southern Biotechnology Associates).
Analysis of protein localization was performed using a Zeiss LSM780 system
equipped with a 30-mW, 405-nm diode laser; 25-mW, 458/488/514 argon
multiline laser; 20-mW DPSS 561-nm; laser; and 5-mW HeNe 633-nm laser
mounted on a Zeiss Axio Observer Z1 and operated with Zen 2011 software
(Zeiss). We used a Plan-Apochromat 633 oil differential interference contrast
(DIC) 1.4 numerical aperture (NA) objective for our observations, and images
were acquired via sequential acquisition.
Immmunoblot
Total cell protein extracts from 3 3 106 purified B cells were lysed in radioim-
munoprecipitation assay (RIPA) buffer (Sigma-Aldrich) supplemented with
protease inhibitors (Complete mini, Roche). Equal amounts of protein (15 mg)
were fractionated by 8% SDS-PAGE, and transferred to a nitrocellulose mem-
brane (Hybond, Amersham). Rabbit anti-mouse polyclonal antibody against
TLR7 (Imgenex) was used for the immunoblot assay. Blots were stripped (strip-
ping buffer, Thermo Fisher), and equal loading was confirmed with a mono-
clonal antibody against b-actin (Abcam).
Generation of Mixed Bone Marrow Chimeras
Chimeras were generated by reconstituting lethally irradiated C57BL/6 mice
with 2 3 107 bone marrow cells from mMT, Unc93b1Letr/Letr, Ifnar/,
or C57BL/6 mice as described previously (Bankoti et al., 2012). The bone
marrow was mixed at a ratio of 4:1 for the following combinations: 80% mMT
with 20% Unc93b1Letr/Letr, 80% mMT with 20% Ifnar/, and 80% mMT with
20% C57BL/6. The reconstitution level was evaluated 6 weeks after bone
marrow transfer (Figure S3). Chimeric mice were infected 7–8 weeks after
reconstitution with 2 3 107 L. donovani-LV9 amastigotes intravenously via
the lateral tail vein.
Flow Cytometry
Endogenous CD4 T cell responses in infected chimera were analyzed as
described previously (Nothelfer et al., 2015). Briefly, splenocytes were either
restimulated with bone marrow-derived dendritic cells (BMDCs) pulsed with
fixed parasites or phorbol 12-myristate 13-acetate (PMA)/ionomycin in the
presence of Brefeldin A (BD Biosciences). Cells were then stained with anti-
CD4-fluorescein isothiocyanate (FITC), anti-CD8 Pacific Blue, anti-IFN-g-allo-
phycocyanin, and anti-IL-10-phycoerythrin (BD Biosciences). 350,000 cells
were acquired on a BD LSRFortessa cell analyzer (Becton Dickinson), and
analysis was performed using FlowJo software (Tree Star).
The expression of costimulatory molecules by B cells from infected
chimeric mice was assessed using the following antibodies: FITC-conjugated
anti-major histocompatibility complex class II (MHCII) (BD Biosciences),
eFluor 450-conjugated anti-CD19 (eBioscience), PE-conjugated anti-CD40
(eBioscience), PE-conjugated anti-CD80 (eBioscience), and PE-conjugated
anti-CD86 (eBioscience). Cells were acquired with a BD LSRFortessa cell
analyzer (Becton Dickinson), and analysis was performed using FlowJo soft-
ware (Tree Star).
Antibody Production
Sera from infected mice were analyzed by ELISA. Total IgM and IgG levels
were measured using the Mouse IgM ELISA Ready-SET-Go! kit and Mouse
IgG ELISA Ready-SET-Go! kit (eBioscience) following manufacturer’s recom-
mendation. Leishmania-specific IgG was measured using the following proto-
col. Nunc Maxisorp 96-well plates (eBioscience) were coated for 2 hr at 37C
and then overnight at 4C with 8 mg of soluble Leishmania antigens (SLAs) in
coating buffer (15 mM Na2CO3 and 35 mM NaH2CO3 [pH 9.6]). Plates were
washed three times with 0.1% Tween 20 in PBS (PBS-T) and further blocked
with 0.1% Tween 20 and 0.5% gelatin for 2 hr at room temperature. After
washing, sera diluted in PBS (1:400) were added and incubated for 2 hr at
37C. Wells were then washed five times with PBS-T, followed by the addition
of enhanced chemiluminescence (ECL) anti-mouse IgG and horseradish
peroxidase-linked species-specific whole antibody (GE Healthcare, Amer-
sham) diluted 1:12,000 in PBS and were incubated for 1 hr at 37C. Substrate
solution (3, tetramethylbenzidine (TMB) liquid substrate, Sigma) was then
added. The reaction was developed at room temperature for 15 min andstoppedwith 1MH2PO4. Absorbancewasmeasured at 450 nm in amicroplate
reader (model 680, Bio-Rad).
Ovalbumin Immunization
C57BL/6, Unc93b1Letr/Letr, and Ifnar/ mice were immunized with 400 mg
ovalbumin (Ova) (Sigma) and 0.05% saponin (Sigma) in sterile PBS at the
base of the tail. Mice were boosted 28 days after the first immunization with
the same amount of protein and adjuvant. Blood was collected weekly by
the lateral saphenous vein; serum was separated by centrifugation and stored
at 80C. Ova-specific IgG were measured following the protocol described
by Garulli et al. (2008). A serial dilution of the sera was performed; the data
represent the results of dilution at 1:200. The reaction was developed at
room temperature for 5 min and stopped with 1 M H2PO4. Absorbance was
measured at 450 nm in a microplate reader (model 680, Bio-Rad).
Statistical Analysis
Statistical analysis was performed using Student’s t test. Differences were
considered to be statistically significant when p < 0.05. All experiments were
conducted independently at least twice.
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